We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Simultaneous Inhibition of Two Enzymes Suppresses Growth of Diffuse Large B-cell Lymphoma

By LabMedica International staff writers
Posted on 01 Aug 2011
Simultaneous blocking of two enzymes has been shown to suppress effectively growth of diffuse large B-cell lymphoma (DLBCL) in a mouse xenograft model and in primary DLBCL cells taken from human patients.

Investigators at the University of Maryland (Baltimore, USA) used a combination of drugs to inhibit the enzymes ERK (extracellular signal-regulated kinase), which acts to regulate cell proliferation and survival, and CHK2 (checkpoint kinase 2), which is involved in responding to cellular DNA damage.

They reported in the July 19, 2011, online edition of the journal Nature Communications that combined inhibition of ERK and CHK2 exerted a potent antitumor effect in a human DLBCL xenograft model and primary DLBCL cells from human patients and may provide a therapeutic advantage. More...
Importantly, the drug combination that inhibited ERK and CHK2 activity did not cause any significant damage to normal cells or tissue.

At the molecular level, the results revealed a positive correlation between ERK and CHK2 expression. ERK physically interacted with CHK2, and inhibition of CHK2 activated ERK.

“The two proteins physically interact, which was not known before, and we may be able to use this interaction for therapeutic advantage,” said senior author Dr. Ronald B. Gartenhaus, associate professor of medicine at the University of Maryland. “We found that treating human B-cell lymphoma cells with both an ERK inhibitor and a CHK2 inhibitor killed substantially more cancer cells than treating the cells with either drug alone. Based on our findings, we believe that a combination therapy targeting both ERK and CHK2 could offer a potential new approach to treating diffuse large B-cell lymphoma.”

Related Links:
University of Maryland




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Automated Clinical Chemistry Analyzer
Envoy 500+
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.